BLOO7 schreef op 27 april 2018 18:07:
Mooie newsflow:
27 April
Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018
25 April
Galapagos reports first quarter 2018 results
24 April
Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
19 April
Galapagos creates new warrant plan
12 April
Galapagos announces ISABELA Phase 3 program in IPF
Op naar de volgende.
Misschien wel zonder data-gegevens, maar o zo belangrijk.